- Home
- ABEO vs ZIMV Comparison
ABEO vs ZIMV Comparison
Compare ABEO & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- ZIMV
- Stock Information
- Founded
- ABEO 1974
- ZIMV 2021
- Country
- ABEO United States
- ZIMV United States
- Employees
- ABEO N/A
- ZIMV N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ABEO Health Care
- ZIMV Health Care
- Exchange
- ABEO Nasdaq
- ZIMV Nasdaq
- Market Cap
- ABEO 256.9M
- ZIMV 262.9M
- IPO Year
- ABEO 1980
- ZIMV N/A
- Fundamental
- Price
- ABEO $5.57
- ZIMV $9.82
- Analyst Decision
- ABEO Strong Buy
- ZIMV Hold
- Analyst Count
- ABEO 6
- ZIMV 2
- Target Price
- ABEO $18.00
- ZIMV $10.00
- AVG Volume (30 Days)
- ABEO 1.1M
- ZIMV 129.8K
- Earning Date
- ABEO 08-11-2025
- ZIMV 07-31-2025
- Dividend Yield
- ABEO N/A
- ZIMV N/A
- EPS Growth
- ABEO N/A
- ZIMV N/A
- EPS
- ABEO N/A
- ZIMV N/A
- Revenue
- ABEO N/A
- ZIMV $443,551,000.00
- Revenue This Year
- ABEO N/A
- ZIMV $1.96
- Revenue Next Year
- ABEO $323.51
- ZIMV $1.95
- P/E Ratio
- ABEO N/A
- ZIMV N/A
- Revenue Growth
- ABEO N/A
- ZIMV N/A
- 52 Week Low
- ABEO $3.93
- ZIMV $8.15
- 52 Week High
- ABEO $7.32
- ZIMV $22.40
- Technical
- Relative Strength Index (RSI)
- ABEO 37.51
- ZIMV 57.30
- Support Level
- ABEO $5.66
- ZIMV $8.39
- Resistance Level
- ABEO $6.24
- ZIMV $9.51
- Average True Range (ATR)
- ABEO 0.26
- ZIMV 0.29
- MACD
- ABEO -0.08
- ZIMV 0.05
- Stochastic Oscillator
- ABEO 8.08
- ZIMV 81.12
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.